| General Information of Drug Metabolite (DM) (ID: DM018119) |
| DM Name |
RaltegravirCglucuronide
|
| Structure |
|
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| Raltegravir potassium |
DR1390
|
Approved |
Human immunodeficiency virus infection |
|
|
| References |
| 1 |
Quantification of the HIV-integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high-performance liquid chromatography tandem mass spectrometry
|
| 2 |
Impact of UGT1A1 polymorphisms on Raltegravir and its glucuronide plasma concentrations in a cohort of HIV-1 infected patients
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
